Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?
Joyce W Y ChanIvan C H SiuAliss T C ChangMolly S C LiRainbow W H LauTony S K MokCalvin Sze-Hang NgPublished in: Cancers (2023)
The demand for parenchyma-sparing local therapies for lung cancer is rising owing to an increasing incidence of multifocal lung cancers and patients who are unfit for surgery. With the latest evidence of the efficacy of lung cancer screening, more premalignant or early-stage lung cancers are being discovered and the paradigm has shifted from treatment to prevention. Transbronchial therapy is an important armamentarium in the local treatment of lung cancers, with microwave ablation being the most promising based on early to midterm results. Adjuncts to improve transbronchial ablation efficiency and accuracy include mobile C-arm platforms, software to correct for the CT-to-body divergence, metal-containing nanoparticles, and robotic bronchoscopy. Other forms of energy including steam vapor therapy and pulse electric field are under intensive investigation.
Keyphrases
- early stage
- ultrasound guided
- minimally invasive
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- risk factors
- computed tomography
- radiofrequency ablation
- stem cells
- squamous cell carcinoma
- prognostic factors
- coronary artery bypass
- percutaneous coronary intervention
- acute coronary syndrome
- magnetic resonance
- radiation therapy
- combination therapy
- positron emission tomography
- peritoneal dialysis
- cell therapy
- image quality
- neoadjuvant chemotherapy
- rectal cancer
- pet ct